Salvatore Calabrese - Chief Financial Officer at Gain Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
GANX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Salvatore Calabrese since 7/7/2023

Holdings reported by Salvatore Calabrese for Gain Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Employee Stock Option (right to buy) 50,000 $293 K $5.86 Mar 23, 2023 Direct Common Stock
Restricted Stock Units 25,000 $62.5 K $2.50 Mar 23, 2023 Direct Common Stock
Common Stock 3,000 $7.38 K $2.46 May 19, 2022 Direct

Transactions reported by Salvatore Calabrese for Gain Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership